As we head into the new year, now is the time to look back on the activity seen in the pharma space in 2025 and consider what it can tell us about the market’s development in 2026.
This month’s cover story look at the rise in deal value across 2025 compared to 2024, considering what fuelled M&A this year and what 2026 may hold.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Another feature looks at the boom in activity in China’s pharma space in 2025.
In this issue, we also review the key talking points from this year’s Clinical Data Management Innovation (CDMI) Europe 2025 conference held in Barcelona.
And don’t miss our further news coverage from the recent CPHI conference held in Frankfurt, Germany.
Read the latest issue of Pharma Technology Focus for all this and insights, and analysis from the pharmaceutical industry.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataYou can also subscribe here to receive email notifications when a new issue is available.
